Royal DSM

DSM
Delayed Euronext Amsterdam - 02/21 05:39:42 pm
116.05EUR
+0.83%
Prev.115.1000
Open114.6500
High116.4000
Low113.8500
Volume611 189
Financials
Sales 2020 9 338 M
EBIT 2020 1 155 M
Net income 2020 840 M
Debt 2020 1 699 M
Yield 2020 2,19%
P/E ratio 2020 23,7x
P/E ratio 2021 21,0x
EV / Sales2020 2,26x
EV / Sales2021 2,10x
Capitalization 19 361 M
Company
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals,...
Sector :
Diversified Chemicals
Calendar :
2020-05-07 Earnings Release
Trading Rating :
Investor Rating :
Latest news
02/21ROYAL DSM : DSM to acquire Glycom to accelerate growth in Early Life Nutrition
PU
02/18ROYAL DSM : DSM - repurchase of shares (10-14 February 2020)
PU
02/13GLOBAL MARKETS LIVE: Elon said it wouldn’t, but Tesla is once again raising billions
02/13ROYAL DSM : DSM reports 2019 results
PU
02/11ROYAL DSM : DSM - repurchase of shares (3-7 February 2020)
PU
02/10ROYAL DSM : annual earnings release
02/04ROYAL DSM : DSM - repurchase of shares (27-31 January 2020)
PU
01/28ROYAL DSM : DSM - repurchase of shares (20-24 January 2020)
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance118118117
Spread/Res.-1,6%-1,6%-1,1%
Spread/Supp.2,8%4,2%8,4%
Support113111107